10x Genomics, Inc. (TXG): R&D Expense
$238.63M
Year ended 2025-12-31
$226.80M
Trailing 12 months to 2026-06-30
-3.5%
3-year compound annual growth
+14.1%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $238.63M | -9.8% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $264.70M | -2.1% | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $270.33M | +1.8% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $265.67M | +25.5% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $211.75M | +71.6% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $123.38M | +48.5% | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | $83.10M | +74.8% | 2022-02-18, From 2019-01-01 |
| 2018-12-31 | $47.54M | +47.8% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $32.16M | n/a | 2020-02-27, From 2017-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $238.63M | -9.8% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $36.47M | -7.4% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $97.31M | -27.9% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $275.60M | -6.9% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $215.84M | +9.7% |
| Quanterix Corp (QTRX) | 2025-12-31 | $35.92M | +15.6% |
| Waters Corp (WAT) | 2025-12-31 | $195.71M | +6.9% |
| Bruker Corp (BRKR) | 2025-12-31 | $395.20M | +5.0% |
| Mettler Toledo International Inc (MTD) | 2025-12-31 | $199.37M | +5.3% |
Compare TXG, CTKB, PACB, BIO side by side · Screen every company in Laboratory Analytical Instruments ↗